TheStreet Upgrades Select Medical (NYSE:SEM) to “B-“

TheStreet upgraded shares of Select Medical (NYSE:SEM) from a c+ rating to a b- rating in a research report report published on Thursday, June 27th, TheStreetRatingsTable reports.

SEM has been the topic of a number of other research reports. ValuEngine upgraded Westpac Banking from a sell rating to a hold rating in a research note on Wednesday, May 22nd. Barclays reiterated a buy rating on shares of Ultragenyx Pharmaceutical in a research note on Thursday, May 9th. JMP Securities upped their price objective on Nice from $140.00 to $164.00 and gave the stock a market outperform rating in a research note on Friday, May 17th. Finally, Zacks Investment Research cut Hamilton Beach Brands from a hold rating to a strong sell rating in a research note on Tuesday, March 12th. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The stock currently has an average rating of Hold and an average target price of $16.67.

NYSE SEM traded up $0.45 during trading on Thursday, hitting $16.10. The stock had a trading volume of 720,306 shares, compared to its average volume of 362,958. The firm has a market cap of $2.18 billion, a P/E ratio of 15.63, a PEG ratio of 1.07 and a beta of 1.26. The company has a 50-day moving average price of $15.33. The company has a debt-to-equity ratio of 4.46, a current ratio of 1.19 and a quick ratio of 1.19. Select Medical has a 12 month low of $12.96 and a 12 month high of $21.65.

Select Medical (NYSE:SEM) last released its earnings results on Thursday, May 2nd. The health services provider reported $0.27 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.27. The firm had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.33 billion. Select Medical had a return on equity of 14.26% and a net margin of 2.80%. The business’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.29 EPS. Sell-side analysts expect that Select Medical will post 1.08 EPS for the current year.

Hedge funds have recently bought and sold shares of the stock. Resources Investment Advisors Inc. acquired a new position in shares of Select Medical during the 4th quarter worth approximately $28,000. Parallel Advisors LLC increased its holdings in shares of Select Medical by 2,889.2% during the 1st quarter. Parallel Advisors LLC now owns 2,481 shares of the health services provider’s stock worth $35,000 after acquiring an additional 2,398 shares during the last quarter. PNC Financial Services Group Inc. increased its holdings in shares of Select Medical by 20.3% during the 4th quarter. PNC Financial Services Group Inc. now owns 6,027 shares of the health services provider’s stock worth $93,000 after acquiring an additional 1,017 shares during the last quarter. NumerixS Investment Technologies Inc increased its holdings in shares of Select Medical by 33.7% during the 4th quarter. NumerixS Investment Technologies Inc now owns 7,486 shares of the health services provider’s stock worth $116,000 after acquiring an additional 1,886 shares during the last quarter. Finally, LPL Financial LLC increased its holdings in shares of Select Medical by 8.2% during the 4th quarter. LPL Financial LLC now owns 10,980 shares of the health services provider’s stock worth $169,000 after acquiring an additional 836 shares during the last quarter. 75.37% of the stock is currently owned by institutional investors and hedge funds.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates through four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

See Also: How Do Investors Open a Backdoor Roth IRA?

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.